COVID-19 Resource Center

Innovation is key to emerging from the COVID-19 pandemic and protecting that innovation with IP is essential. Here, we present our COVID-19-related information.

As the world grapples with the COVID-19 pandemic, our attorneys are helping clients navigate the complex intellectual property issues involved in developing testing, treatments, and vaccines, as well as related products and services to combat the disease. Additionally, our thought leaders are publishing articles, leading panel discussions, and serving as sources to the media in order to contribute to the global conversation about solutions to the crisis. Of course, innovation is key to emerging from the pandemic, and protecting that innovation is essential. Here, for your easy reference, we present our content related to COVID-19 and intellectual property considerations. Please do not hesitate to contact us for further information and/or to discuss your specific IP questions and concerns.

Related News & Insights

In the News

March 13, 2020

USPTO Meetings Ban Due To Virus Unlikely To Disrupt Cases

Law360

Bylined Articles

March 11, 2020

Patenting Compounds, Compositions, and Methods for Viral Infections

Bloomberg Law

Bylined Articles

March 4, 2020

Vaccine IP Under Microscope With Coronavirus Outbreak

Law360